Contents
Current Drug Targets - Inflammation & Allergy, Volume 3 - Number 2
Preface [Hot topic: Psoriasis (Guest Editor: Giampiero Girolomoni)]
, 3(2): iGiampiero Girolomoni
DOI: 10.2174/1568010043343921
The Psoriasis Genetics as a Model of Complex Disease
, 3(2): 129 - 136Emiliano Giardina, Cecilia Sinibaldi and Giuseppe Novelli
DOI: 10.2174/1568010043343877
Immunopathogenesis of Psoriasis
, 3(2): 137 - 144Maki Ozawa and Setsuya Aiba
DOI: 10.2174/1568010043343868
Established Treatments of Psoriasis
, 3(2): 145 - 156Peter C.M. van de Kerkhof and Wijnand H.P.M. Vissers
DOI: 10.2174/1568010043343967
T-Cell-Targeted Biologicals for Psoriasis
, 3(2): 157 - 161Christopher E.M. Griffiths
DOI: 10.2174/1568010043343912
Targeting Selectin Functions in the Therapy of Psoriasis
, 3(2): 163 - 168Michael P. Schon, Claudia Drewniok and W. -Henning Boehncke
DOI: 10.2174/1568010043343895
Targeting Tumor Necrosis Factor-α in the Therapy of Psoriasis
, 3(2): 175 - 183Paolo Gisondi, Emanuela Gubinelli, Barbara Cocuroccia and Giampiero Girolomoni
DOI: 10.2174/1568010043343903
Interleukin-10: An Important Immunoregulatory Cytokine With Major Impact on Psoriasis
, 3(2): 185 - 192Khusru Asadullah, Robert Sabat, Markus Friedrich, Hans Dieter Volk and Wolfram Sterry
DOI: 10.2174/1568010043343886
Immune Deviation Strategies in the Therapy of Psoriasis
, 3(2): 193 - 198Kamran Ghoreschi and Martin Rocken
DOI: 10.2174/1568010043343949
New Vitamin D Analogs in Psoriasis
, 3(2): 199 - 204Karsten Fogh and Knud Kragballe
DOI: 10.2174/1568010043343930
Peroxisome Proliferator-Activated Receptors as New Molecular Targets in Psoriasis
, 3(2): 205 - 211Stephane Kuenzli and Jean-Hilaire Saurat
DOI: 10.2174/1568010043343976
Histone Deacetylase Inhibitors in Psoriasis Therapy
, 3(2): 213 - 219Fiona McLaughlin and Nicholas B. La Thangue
DOI: 10.2174/1568010043343859
Webmaster Contact: info@benthamscience.org